Induction of 'blocking' IgG antibodies during immunotherapy.
Wachholz
P A
PA
Durham
S R
SR
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000485:Allergens / Q000276:immunology; D016207:Cytokines / Q000276:immunology; D006801:Humans; D006967:Hypersensitivity / Q000276:immunology / Q000628:therapy*; D007073:Immunoglobulin E / Q000276:immunology; D007074:Immunoglobulin G / Q000276:immunology*; D007167:Immunotherapy / Q000379:methods*; D008050:Lipid A / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008070:Lipopolysaccharides / Q000627:therapeutic use; D017455:Receptors, IgE / Q000276:immunology
D000276:Adjuvants, Immunologic; D000485:Allergens; D016207:Cytokines; D007074:Immunoglobulin G; D008050:Lipid A; D008070:Lipopolysaccharides; D017455:Receptors, IgE; D007073:Immunoglobulin E; C048436:monophosphoryl lipid A